Teva to acquire migraine drug firm at $825 mn
Generics | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2014
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...Read more
Mayne Pharma appoints a new vice president
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2014
Singapore: Australian drug maker Mayne Pharma announced Mr Blake Cullen as the new vice president of business developmen...Read more
GSK seeks FIPB nod to hike stake in India
Generics | News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2014
Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake ...Read more
Pharma FDI cap, right move for India
Generics | Opinion | By Nandita Singh | 0 Comment | 31 Jul, 2012
India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brown...Read more
GSK CEO: London HQ 'knew nothing' of the fraud
Generics | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest d...Read more
FDA nod for Lupin's angina generic Ranolazine
Generics | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013
Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg...Read more
Eli Lilly files $500 mn suit against Canada govt
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the co...Read more
DRL launches Alchemia thrombosis generic in India
Generics | News | By BioSpectrum Bureau | 0 Comment | 04 Apr, 2013
Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...Read more
Abbott Laboratories unveils strategy for India
Generics | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push ...Read more
Pfizer to acquire Innopharma at $360 mn
Generics | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2014
Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, in...Read more
Mylan launches operations in India with 18 ARV products
Generics | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2012
Bangalore: Mylan Pharmaceuticals, a subsidiary of Mylan, has commenced commercial operations in India, starting with the...Read more
Mundipharma appoints John Lee as GM for SEA
Generics | Influencers | By BioSpectrum Bureau | 5 Comment | 06 Nov, 2013
Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, t...Read more
Dr Reddy's launches Eszopiclone tablets in US
Generics | News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2014
Singapore: Dr Reddy's Laboratories has launched sedative drug, Eszopiclone tablets (C-IV) 1 mg, 2 mg and 3 mg, a therape...Read more
Bioscience firms queue up for Japan market
Generics | Analysis | By BioSpectrum Bureau | 2 Comment | 01 Jun, 2012
Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...Read more
FDA clears 152 antiretroviral drugs for HIV/AIDS program
Generics | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: The US Food and Drug Administration (FDA) has approved or tentatively approved a total of 152 antiretroviral ...Read more
Wockhardt gets FDA nod for generic treatment of enlarged prostate
Generics | News | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2012
Mumbai: Pharmaceutical and biotechnology major Wockhardt has received final approval from the US Food & Drug Adminis...Read more
RPG issued warning letter by US FDA
Generics | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Jun, 2013
Singapore: In what has come as another shocker for the Indian Pharmaceutical industry, the US FDA slammed RPG Life Scien...Read more
Dr. Reddy's rides on biosimilar product line
Generics | Analysis | By BioSpectrum Bureau | 1 Comment | 15 Jun, 2012
India-headquartered Dr Reddy's Laboratories is making a strong name in biosimilars business in India and in the world....Read more